Adolorin Ibuforte 400 mg Dragees
Recall | Medicines | 30/09/2020
The marketing authorisation holder informed its customers on September 29, 2020 that a reduced release of the active substance was detected in the concerned batch.
Therefore, this batch will be recalled.
|Name of the medicinal product||Adolorin Ibuforte 400 mg Dragees|
|Marketing authorisation number(s)||1-24505|
|Marketing authorisation holder||Kwizda Pharma GmbH|
|Classification of the recall||2|
|Depth of recall||Pharmacies|
|BASG reference number||INS-640.001-3330|
Further inquiry note
Page last modified: 30/09/2020